Skip to main content
. 2023 Sep 14;9(9):e20153. doi: 10.1016/j.heliyon.2023.e20153

Table 4.

The subgroup analysis of included published studies.

Analysis No. of studies Sample size OR 95% CI P
Brazil
Adverse events 2 460 0.92 0.82 to 1.03 0.15
Serious adverse event 1 179 0.97 0.25 to 3.75 0.96
China
Adverse events 2 368 0.79 0.61 to 1.02 0.07
Serious adverse event 2 368 0.33 0.04 to 2.69 0.3
Russia
Adverse events 1 314 0.97 0.64 to 1.47 0.89
Serious adverse event 1 314 0.33 0.01 to 8.12 0.5